The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended extending the therapeutic indication of Amgen Inc.’s Uplizna (inebilizumab) to include the treatment of adult patients with active immunoglobulin G4-related disease (IgG4-RD). IgG4-RD is a rare, chronic, autoimmune condition (a disease caused by the body’s own defence system attacking normal tissue) that can cause fibrosis (tissue scarring) and inflammation in...

01:17 PM EDT, 09/19/2025 (MT Newswires) -- Red Cat Holdings ( RCAT ) said Friday that it has closed an underwritten public offering of about 18 million common shares, which includes 2.34 million shares from the underwriters' option, for gross proceeds of $172.5 million. The company intends to use the proceeds for general corporate purposes and working capital, including funding...

01:01 PM EDT, 09/19/2025 (MT Newswires) -- Consumer stocks were mixed Friday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) easing 0.2% and the Consumer Discretionary Select Sector SPDR Fund (XLY) adding 0.4%. In corporate news, Lennar ( LEN ) shares were down 4% after the homebuilder issued fiscal Q4 delivery outlook below market estimates, while it reported...

* Cenovus says no precedent to indicate MEG should be worth more than offer * Cenovus aims to create large oil sands producer with MEG * MEG board endorses the bid * MEG shareholders to vote Oct 9 By Amanda Stephenson CALGARY, Sept 19 (Reuters) - The CEO of Canada's Cenovus Energy ( CVE ) pushed back on Friday against...